Get the Stockscreener App
34.00
0.80%
0.27
Crinetics Pharmaceuticals Inc stock is traded at $34.00, with a volume of 1.15M.
It is up +0.80% in the last 24 hours and up +19.38% over the past month.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.
See More
Previous Close:
$33.73
Open:
$33.55
24h Volume:
1.15M
Relative Volume:
1.25
Market Cap:
$3.20B
Revenue:
$4.72M
Net Income/Loss:
$-277.91M
P/E Ratio:
-9.1153
EPS:
-3.73
Net Cash Flow:
$-203.56M
1W Performance:
-4.52%
1M Performance:
+19.38%
6M Performance:
-3.95%
1Y Performance:
-33.63%
1-Day Range:
$33.46
$34.32
1-Week Range:
$33.19
$37.23
52-Week Range:
$24.10
$62.53
Crinetics Pharmaceuticals Inc Stock (CRNX) Company Profile
Name
Crinetics Pharmaceuticals Inc
Sector
Industry
Phone
858-450-6464
Address
6055 LUSK BLVD., SAN DIEGO, CA
Compare CRNX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CRNX
Crinetics Pharmaceuticals Inc
|
34.00 | 3.30B | 4.72M | -277.91M | -203.56M | -3.73 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Crinetics Pharmaceuticals Inc Stock (CRNX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-10-25 | Initiated | Goldman | Neutral |
| Mar-25-25 | Initiated | Stifel | Buy |
| Feb-11-25 | Initiated | TD Cowen | Buy |
| Feb-04-25 | Initiated | Wolfe Research | Peer Perform |
| Jan-22-25 | Upgrade | Jefferies | Hold → Buy |
| Mar-06-24 | Initiated | Citigroup | Buy |
| Jan-16-24 | Initiated | Morgan Stanley | Overweight |
| Dec-21-23 | Initiated | Jefferies | Hold |
| Nov-20-23 | Resumed | JP Morgan | Overweight |
| Oct-24-23 | Resumed | Cantor Fitzgerald | Overweight |
| Aug-31-23 | Initiated | Oppenheimer | Outperform |
| Apr-24-23 | Initiated | Piper Sandler | Overweight |
| Mar-30-23 | Initiated | Robert W. Baird | Outperform |
| Nov-30-21 | Initiated | JMP Securities | Mkt Outperform |
| Nov-23-21 | Initiated | Evercore ISI | Outperform |
| Jun-18-21 | Upgrade | JP Morgan | Neutral → Overweight |
| Dec-23-19 | Initiated | ROTH Capital | Buy |
| Feb-14-19 | Initiated | H.C. Wainwright | Buy |
| Aug-13-18 | Initiated | JP Morgan | Neutral |
| Aug-13-18 | Initiated | Leerink Partners | Outperform |
| Aug-13-18 | Initiated | Piper Jaffray | Overweight |
View All
Crinetics Pharmaceuticals Inc Stock (CRNX) Latest News
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Parkman Healthcare Partners LLC Purchases 12,807 Shares of Crinetics Pharmaceuticals, Inc. $CRNX - MarketBeat
51,295 Shares in Crinetics Pharmaceuticals, Inc. $CRNX Acquired by Exome Asset Management LLC - MarketBeat
Crinetics Pharmaceuticals Announces September 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
62,475 Stock Options at $35/Share: Crinetics Pharmaceuticals Awards Inducement Grants to New Hires - Stock Titan
Cormorant Asset Management LP Has $20.12 Million Stock Holdings in Crinetics Pharmaceuticals, Inc. $CRNX - MarketBeat
Can Crinetics Pharmaceuticals Inc. outperform under higher oil pricesMarket Activity Summary & Short-Term High Return Strategies - beatles.ru
Is Crinetics Pharmaceuticals Inc. stock forming a triangle patternJuly 2025 News Drivers & Verified Momentum Watchlists - beatles.ru
AWM Investment Company Inc. Has $3.19 Million Stake in Crinetics Pharmaceuticals, Inc. $CRNX - MarketBeat
Crinetics Pharmaceuticals (NASDAQ:CRNX) Stock Price Up 6.1%Here's Why - MarketBeat
What machine learning models say about Crinetics Pharmaceuticals Inc.Market Trend Review & Advanced Swing Trade Entry Alerts - Newser
How to interpret RSI for Crinetics Pharmaceuticals Inc. stockJuly 2025 Closing Moves & Safe Capital Growth Stock Tips - Newser
What’s the analyst consensus on Crinetics Pharmaceuticals Inc.Quarterly Performance Summary & Detailed Earnings Play Alerts - خودرو بانک
Regression analysis insights on Crinetics Pharmaceuticals Inc. performanceJuly 2025 Snapshot & Entry and Exit Point Strategies - Newser
Can Crinetics Pharmaceuticals Inc. outperform in the next rally2025 Fundamental Recap & Smart Investment Allocation Insights - خودرو بانک
Advanced analytics toolkit walkthrough for Crinetics Pharmaceuticals Inc.2025 Retail Activity & High Accuracy Swing Entry Alerts - Newser
Technical analysis overview for Crinetics Pharmaceuticals Inc. stockMarket Growth Report & Reliable Trade Execution Plans - Newser
What is Crinetics Pharmaceuticals Inc. s P E ratio telling usDay Trade & Stepwise Trade Execution Plans - خودرو بانک
Volume spikes in Crinetics Pharmaceuticals Inc. stock – what they mean2025 Market Outlook & Intraday High Probability Setup Alerts - Newser
Crinetics Pharmaceuticals Inc. Could See a Relief Rally From SupportWeekly Stock Analysis & AI Powered Buy and Sell Recommendations - beatles.ru
Crinetics Pharmaceuticals Inc. stock volume spike explainedPortfolio Performance Summary & Step-by-Step Swing Trade Plans - Newser
Paradigm Biocapital Advisors LP Has $65.27 Million Stock Position in Crinetics Pharmaceuticals, Inc. $CRNX - MarketBeat
Building trade automation scripts for Crinetics Pharmaceuticals Inc.Trade Analysis Summary & Detailed Earnings Play Alerts - Newser
Crinetics Pharmaceuticals CEO Pizzuti Dana Sells Shares After Buying at Lower Price - AInvest
Geopolitics Watch: Should value investors consider Crinetics Pharmaceuticals Inc.July 2025 Volume & Short-Term Trading Alerts - خودرو بانک
Using flow based indicators on Crinetics Pharmaceuticals Inc.Earnings Performance Report & Fast Entry Momentum Trade Alerts - Newser
Crinetics Pharmaceuticals, Inc. $CRNX Shares Acquired by Rafferty Asset Management LLC - MarketBeat
Should you wait for a breakout in Crinetics Pharmaceuticals Inc.2025 Technical Overview & Accurate Intraday Trade Tips - Newser
Detecting price anomalies in Crinetics Pharmaceuticals Inc. with AIPortfolio Growth Summary & Community Verified Trade Signals - Newser
Published on: 2025-09-03 08:54:39 - Newser
Crinetics: Low Expectations As The PDUFA Clock Ticks To Zero - Seeking Alpha
Crinetics Pharmaceuticals Soars 10.36% on Bullish Outlook - AInvest
Using Ichimoku Cloud for Crinetics Pharmaceuticals Inc. technicals2025 Earnings Surprises & Low Risk Entry Point Guides - Newser
How to build a custom watchlist for Crinetics Pharmaceuticals Inc.2025 Market Sentiment & Community Consensus Trade Alerts - Newser
Crinetics Pharmaceuticals, Inc. $CRNX is Driehaus Capital Management LLC's 3rd Largest Position - MarketBeat
Will Crinetics Pharmaceuticals Inc. stock recover after recent drop2025 Price Targets & Safe Entry Point Identification - Newser
Is Crinetics Pharmaceuticals Inc. stock reversal real or fakeMarket Risk Summary & Weekly High Potential Stock Alerts - Newser
What momentum shifts mean for Crinetics Pharmaceuticals Inc.Earnings Recap Report & AI Driven Stock Reports - Newser
How to monitor Crinetics Pharmaceuticals Inc. with trend dashboardsGold Moves & AI Forecast for Swing Trade Picks - Newser
What’s the recovery path for long term holders of Crinetics Pharmaceuticals Inc.Weekly Risk Summary & Weekly High Potential Stock Alerts - Newser
Published on: 2025-09-02 06:24:06 - Newser
Combining price and volume data for Crinetics Pharmaceuticals Inc.CEO Change & Daily Stock Trend Reports - Newser
Is Crinetics Pharmaceuticals Inc.’s ROE strong enough2025 Price Momentum & Precise Entry and Exit Recommendations - خودرو بانک
Crinetics Pharmaceuticals Inc. stock trend forecastWall Street Watch & Risk Managed Trade Strategies - Newser
Is Crinetics Pharmaceuticals Inc. likely to announce a buybackWeekly Earnings Recap & Consistent Profit Trading Strategies - خودرو بانک
Will Crinetics Pharmaceuticals Inc. stock go up in YEARWeekly Market Outlook & Weekly Top Stock Performers List - خودرو بانک
Will Crinetics Pharmaceuticals Inc. benefit from seasonality2025 Market Overview & Community Trade Idea Sharing - خودرو بانک
Published on: 2025-09-01 15:42:21 - Newser
Should value investors consider Crinetics Pharmaceuticals Inc.Bond Market & Target Return Focused Picks - khodrobank.com
How to forecast Crinetics Pharmaceuticals Inc. trends using time seriesForecast Cut & Real-Time Volume Spike Alerts - Newser
Crinetics Pharmaceuticals Inc Stock (CRNX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Crinetics Pharmaceuticals Inc Stock (CRNX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Pizzuti Dana | Chief Med and Dev Officer |
Sep 02 '25 |
Sale |
32.10 |
5,000 |
160,500 |
96,270 |
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):